Literature DB >> 19262381

Luteal support in reproduction: when, what and how?

Mohamed Aboulghar1.   

Abstract

PURPOSE OF REVIEW: Luteal phase support (LPS) is an integral part of the IVF cycles treated by gonadotropin-releasing hormone analogues. There is a worldwide controversy concerning the type of hormones used for LPS, its dose, duration, when to start and when to stop. This review will cover original as well as recent data on this topic. RECENT
FINDINGS: There is a consensus in the literature among IVF centers that LPS is necessary for IVF cycles. Human chorionic gonadotropin is less commonly used than progesterone for LPS because of ovarian hyperstimulation syndrome risk. Several studies suggested that intramuscular progesterone is superior to vaginal progesterone for LPS; however, the majority of centers use vaginal progesterone to avoid side effects of intramuscular injection. There is no difference in pregnancy rate whether LPS is started on day of human chorionic gonadotropin, oocyte retrieval or embryo transfer. There is a strong evidence that LPS should be stopped either on the day of pregnancy test or the first ultrasound (6-7 weeks pregnancy). There is no evidence that addition of estrogen will improve pregnancy rate.
SUMMARY: Progesterone is the preferred option for LPS. It should start within 2 days from triggering ovulation and should end on day of beta human chorionic gonadotropin or the day of the first ultrasound (6-7 weeks pregnancy).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262381     DOI: 10.1097/GCO.0b013e32832952ab

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  7 in total

1.  Addition of gonadotropin releasing hormone agonist for luteal phase support in in-vitro fertilization: an analysis of 2739 cycles.

Authors:  Erhan Şimşek; Esra Bulgan Kılıçdağ; Pınar Çağlar Aytaç; Gonca Çoban; Seda Yüksel Şimşek; Tayfun Çok; Bülent Haydardedeoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

Review 2.  Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse.

Authors:  Lingling Salang; Danielle M Teixeira; Ivan Solà; Jen Sothornwit; Wellington P Martins; Magdalena Bofill Rodriguez; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2022-08-24

3.  A ray of hope for a woman with Sheehan's syndrome.

Authors:  Deepti Jain
Journal:  BMJ Case Rep       Date:  2013-02-04

4.  The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles - a randomized controlled study.

Authors:  Ashraf Moini; Shahrzad Zadeh Modarress; Elham Amirchaghmaghi; Naeimeh Mirghavam; Soraya Khafri; Mohammad Reza Akhoond; Reza Salman Yazdi
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

Review 5.  Estrogen supplementation to progesterone as luteal phase support in patients undergoing in vitro fertilization: systematic review and meta-analysis.

Authors:  Xiao-Mei Zhang; Fang Lv; Pin Wang; Xia-Man Huang; Kai-Feng Liu; Yu Pan; Nai-Jun Dong; Yu-Rong Ji; Hong She; Rong Hu
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

6.  Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles.

Authors:  Kenan Sofuoglu; Ismet Gun; Sadik Sahin; Okan Ozden; Oktay Tosun; Mustafa Eroglu
Journal:  Pak J Med Sci       Date:  2015 Mar-Apr       Impact factor: 1.088

Review 7.  Estradiol use in the luteal phase and its effects on pregnancy rates in IVF cycles with GnRH antagonist: a systematic review.

Authors:  Lanna Marla Andrade Pinheiro; Priscilla da Silva Cândido; Tássia Camila Moreto; Wanessa Gonzaga Di Almeida; Eduardo Camelo de Castro
Journal:  JBRA Assist Reprod       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.